Skip to content

Study on the clinical and mechanism of

Study on the clinical and mechanism of

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066561
Enrollment
Unknown
Registered
2022-12-09
Start date
2022-12-09
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

Control group : Conventional acupuncture
Experimental group:“Tiaoshen liqi"acupuncture

Sponsors

Heilongjiang University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ? Patients who meet the diagnostic criteria, and no abnormality is found through head CT or MRI; ? 18 = 60 years old, and the age of first onset is less than 50 years old; ? At least 2 attacks per month, less than 15 days of headache per month, and migraine history = 1 year; ? The patient or his family members agree to sign the informed consent form.

Exclusion criteria

Exclusion criteria: ?Headache is caused by other diseases (such as hypertension, epilepsy, etc.) ?Pregnant or lactating women ?Patients with serious primary diseases such as cardiovascular, urinary, digestive and blood systems ?Patients with cognitive impairment, aphasia, dyslexia and other symptoms ?Patients unable to cooperate with treatment or fill in the scale correctly ?Alcohol or drug abusers

Design outcomes

Primary

MeasureTime frame
Definition of migraine day;Definition of moderate/severe headache day;

Secondary

MeasureTime frame
Definition of responder rate;Headache severity;PHQ-9;GAD-7;PSQI;HIT-6;Cerebral hemodynamic indicators;MSQ;

Countries

China

Contacts

Public ContactSongXue/ Wei Zou

The First Affiliated Hospital of Heilongjiang University of Chinese Medicine

410064505@qq.com15145036499

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026